Black History MonthCancer History ProjectConversation with The Cancer LetterFree Harold Freeman, father of patient navigation, on cutting the cancer out of Harlem February 11, 2022Vol.48 No.06By Robert A. Winn and John H. Stewart
FreeObituary Bill Vaughan, bone marrow transplantation pioneer, dies at 75 February 11, 2022Vol.48 No.06By Samuel M. Silver
FreeIn the Archives Cancer History Project launches oral history podcast February 11, 2022Vol.48 No.06
Trials & Tribulations Here’s how we can make clinical trials more inclusive February 11, 2022Vol.48 No.06By Jenny Sherak
Conversation with The Cancer LetterRegulatory News FDA says it had no input as companies developed checkpoint inhibitors in China February 04, 2022Vol.48 No.05By Paul Goldberg
White House Biden reignites Cancer Moonshot, convenes “Cancer Cabinet” to increase screening and halve cancer deaths before 2050 February 04, 2022Vol.48 No.05By Alice Tracey and Matthew Bin Han Ong
Guest Editorial Congressional inaction harms federally funded oncology research and our patients:The time for the cancer community to act is now February 04, 2022Vol.48 No.05By Howard A. "Skip" Burris III, Charles D. Blanke, Monica M. Bertagnolli, Peter J. O'Dwyer, Mitchell D. Schnall, Douglas S. Hawkins, Quynh-Thu Le, Robert S. Mannel, Norman Wolmark and Janet Dancey
Black History MonthCancer History ProjectConversation with The Cancer LetterFree Wayne Frederick on the legacy of LaSalle Leffall, Jr. February 04, 2022Vol.48 No.05By Robert A. Winn
Trials & Tribulations Leveraging cutting-edge technology to address the impact of COVID-19 on cancer screening, diagnosis, and treatment February 04, 2022Vol.48 No.05By Gustaf Salford
